Renal denervation in patients with versus without chronic kidney disease: results from the Global SYMPLICITY Registry with follow-up data of 3 years
The DOI matches its Crossref record; 35 of the 36 references it cites were found in a registry or an index.
Abstract
Background: Activity of the sympathetic nervous system is increased in patients with hypertension and chronic kidney disease (CKD). Here we compare short- and long-term blood pressure (BP)-lowering effects of renal denervation (RDN) between hypertensive patients with or without CKD in the Global SYMPLICITY Registry. Methods: Office and 24-h ambulatory BP (ABP) were assessed at prespecified time points after RDN. The presence of CKD was defined according to the estimated glomerular filtration rate (eGFR) and enrolled patients were stratified based on the presence (n = 475, eGFR <60 mL/min/1.73 m2) or absence (n = 1505, eGFR ≥60mL/min/1.73 m2) of CKD. Results: Patients with CKD were older (P < 0.001) and were prescribed more antihypertensive medications (P < 0.001). eGFR decline per year was not significantly different between groups after the first year. Office and 24-h ABP were significantly reduced from baseline at all time points after RDN in both groups (all P < 0.001). After adjusting for baseline data, patients without CKD had a greater reduction in office systolic BP (−17.3 ± 28.3 versus −11.7 ± 29.9 mmHg; P = 0.009) but not diastolic BP at 36 months compared with those with CKD. Similar BP and eGFR results were found when the analysis was limited to patients with both baseline and 36-month BP data available. There was no difference in the safety profile of the RDN procedure between groups. Conclusions: After adjusting for baseline data, 24-h systolic and diastolic ABP reduction were similar in patients with and without CKD after RDN, whereas office systolic but not diastolic BP was reduced less in patients with CKD. We conclude that RDN is an effective antihypertensive treatment option in CKD patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A meta-analysis of data from the Global SYMPLICITY Registry found similar anti-hypertensive effects of RDN in patients with and without CKD (eGFR <60 ml/min/1.73 m2 and >60 ml/min/1.73 m2 respectively)114.”
From Renal nerves in physiology, pathophysiology and interoception (2025) · cites this paper as [114]
In the citing paper
“Importantly, clinical data suggest that no differences exist between the safety outcomes of RDN in patients with and those without CKD114.”
From Renal nerves in physiology, pathophysiology and interoception (2025) · cites this paper as [114]
Citations
Cites
A New Equation to Estimate Glomerular Filtration Rate
Levey, A. S., Stevens, L. A., Schmid, C. H., Zhang, Y. (., Castro, A. F., Feldman, H. I., Kusek, J. W., Eggers, P., Van Lente, F., Greene, T., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-9-200905050-00006 · Cited by 25,603
Tarver, T. (2014) · Journal of Consumer Health On the Internet · doi:10.1080/15398285.2014.902284 · Cited by 5,605
A Controlled Trial of Renal Denervation for Resistant Hypertension
Bhatt, D. L., Kandzari, D. E., O'Neill, W. W., D'Agostino, R., Flack, J. M., Katzen, B. T., Leon, M. B., Liu, M., Mauri, L., Negoita, M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402670 · Cited by 2,186
Krum, H., Schlaich, M., Whitbourn, R., Sobotka, P. A., Sadowski, J., Bartus, K., Kapelak, B., Walton, A., Sievert, H., Thambar, S., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60566-3 · Cited by 2,108
Self-citationEuropean Society of hypertension position paper on ambulatory blood pressure monitoring
O’Brien, E., Parati, G., Stergiou, G., Asmar, R., Beilin, L., Bilo, G., Clement, D., de la Sierra, A., de Leeuw, P., Dolan, E., et al. (2013) · Journal of Hypertension · doi:10.1097/hjh.0b013e328363e964 · Cited by 1,419
Self-citationNeural control of renal function
DiBona, G. F., & Kopp, U. C. (1997) · Physiological Reviews · doi:10.1152/physrev.1997.77.1.75 · Cited by 1,212
Effect of systolic and diastolic blood pressure on cardiovascular outcomes
Flint, A. C., Conell, C., Ren, X., Banki, N. M., Chan, S. L., Rao, V. A., Melles, R. B., & Bhatt, D. L. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1803180 · Cited by 684
Sympathetic Nerve Activity in End-Stage Renal Disease
Hausberg, M., Kosch, M., Harmelink, P., Barenbrock, M., Hohage, H., Kisters, K., Dietl, K. H., & Rahn, K. H. (2002) · Circulation · doi:10.1161/01.cir.0000034043.16664.96 · Cited by 493
Mahmoodi, B. K., Matsushita, K., Woodward, M., Blankestijn, P. J., Cirillo, M., Ohkubo, T., Rossing, P., Sarnak, M. J., Stengel, B., Yamagishi, K., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61272-0 · Cited by 452
Research works printed but not linked: 1
- Mozaffarian, 2015, Heart disease and stroke statistics—2015 update: a report from the American Heart Association, Circulation, 131, e29
Cited by
Hypertension management in patients with cardiovascular comorbidities
Lauder, L., Mahfoud, F., Azizi, M., Bhatt, D. L., Ewen, S., Kario, K., Parati, G., Rossignol, P., Schlaich, M. P., Teo, K. K., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehac395 · Cited by 210
Self-citationBarbato, E., Azizi, M., Schmieder, R. E., Lauder, L., Böhm, M., Brouwers, S., Bruno, R. M., Dudek, D., Kahan, T., Kandzari, D. E., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad054 · Cited by 188
“Only 0.3% of the patients without chronic kidney disease at base-line had new onset end-stage kidney disease at the 3-year follow-up 27 .”
InfluentialSelf-citationDiagnosis and treatment of arterial hypertension 2021
Ott, C., & Schmieder, R. E. (2021) · Kidney International · doi:10.1016/j.kint.2021.09.026 · Cited by 151
Self-citationCluett, J., Blazek, O., Brown, A. L., East, C. A., Ferdinand, K. C., Fisher, N. D. L., Ford, C. D., Griffin, K. A., Mena‐Hurtado, C., Sarathy, H., et al. (2024) · Hypertension · doi:10.1161/hyp.0000000000000240 · Cited by 128
Law, J. P., Pickup, L. C., Pavlović, D., Townend, J., & Ferro, C. J. (2022) · Journal of Human Hypertension · doi:10.1038/s41371-022-00751-4 · Cited by 139
Renal denervation: basic and clinical evidence
Katsurada, K., Shinohara, K., Aoki, J., Nanto, S., & Kario, K. (2021) · Hypertension Research · doi:10.1038/s41440-021-00827-7 · Cited by 87
Diagnosis and management of resistant hypertension
Schiffrin, E. L., & Fisher, N. D. L. (2024) · BMJ · doi:10.1136/bmj-2023-079108 · Cited by 83
Renal nerves in physiology, pathophysiology and interoception
Evans, L. C., Dayton, A., & Osborn, J. W. (2025) · Nature Reviews Nephrology · doi:10.1038/s41581-024-00893-3 · Cited by 46
Renal denervation in patients with chronic kidney disease: current evidence and future perspectives
Schmieder, R. E. (2023) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfac189 · Cited by 39
“In the Global Symplicity Registry, the largest cohort followed currently, reductions in both office and ambulatory BP have been sustained over a 3-year period [37].”
BackgroundInfluentialSelf-citationBarbato, E., Azizi, M., Schmieder, R. E., Lauder, L., Böhm, M., Brouwers, S., Bruno, R. M., Dudek, D., Kahan, T., Kandzari, D. E., et al. (2023) · EuroIntervention · doi:10.4244/eij-d-22-00723 · Cited by 29
Self-citationRenal denervation in the antihypertensive arsenal – knowns and known unknowns
Messerli, F. H., Bavishi, C., Brguljan-Hitij, J., Burnier, M., Dobner, S., Elijovich, F., Ferdinand, K. C., Kjeldsen, S. E., Laffer, C. L., Ram, C. V. S., et al. (2022) · Journal of Hypertension · doi:10.1097/hjh.0000000000003171 · Cited by 23
Self-citationXin-Ru, H. U., Liao, G., Wang, J., Ye, Y., Chen, X., Bai, L., Shi, F., Liu, K., & Peng, Y. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.124.034915 · Cited by 22
Renal denervation in the management of hypertension
Lauder, L., Kandzari, D. E., Lüscher, T. F., & Mahfoud, F. (2024) · EuroIntervention · doi:10.4244/eij-d-23-00836 · Cited by 21
Self-citationRenal Denervation in Patients With Moderate to Severe Chronic Kidney Disease
Schlaich, M. P., Mahfoud, F., Böhm, M., Narkiewicz, K., Ruilope, L. M., Williams, B., Mancia, G., Sharif, F., Ribichini, F. L., Lung, T., et al. (2025) · Hypertension · doi:10.1161/hypertensionaha.125.25470 · Cited by 20
Self-citationPatient Selection for Renal Denervation in Hypertensive Patients: What Makes a Good Candidate?
Li, S., & Phillips, J. K. (2022) · Vascular Health and Risk Management · doi:10.2147/vhrm.s270182 · Cited by 15
Sato, Y., Sharp, A. S. P., Mahfoud, F., Tunev, S. S., Forster, A., Ellis, M., Gomez, A., Dhingra, R., Ullman, J., Schlaich, M. P., et al. (2023) · EuroIntervention · doi:10.4244/eij-d-22-00369 · Cited by 13
Self-citationEffects of renal denervation on the kidney: albuminuria, proteinuria, and renal function
Yamazaki, D., Konishi, Y., & Kitada, K. (2024) · Hypertension Research · doi:10.1038/s41440-024-01709-4 · Cited by 11
Feriozzi, S., Battaglia, Y., Cirami, C. L., Gangemi, C., Manna, G. L., Gesualdo, L., Muiesan, M. L., Pani, A., Pieruzzi, F., Ribichini, F. L., et al. (2025) · Journal of Nephrology · doi:10.1007/s40620-025-02406-2 · Cited by 12
Renal Denervation to Treat Hypertension: A Clinical State-of-the-Art Review
Sharp, A. S. P., & Fisher, N. D. L. (2025) · American Journal of Hypertension · doi:10.1093/ajh/hpaf134 · Cited by 13
Update on Renal Sympathetic Denervation for the Treatment of Hypertension
Rao, A., & Krishnan, N. (2022) · Current Cardiology Reports · doi:10.1007/s11886-022-01753-x · Cited by 10
Blood pressure reduction after renal denervation in patients with or without chronic kidney disease
Günes-Altan, M., Schmid, A., Ott, C., Bosch, A., Pietschner, R., Schiffer, M., Uder, M., Schmieder, R. E., & Kannenkeril, D. (2023) · Clinical Kidney Journal · doi:10.1093/ckj/sfad237 · Cited by 12
Self-citationMazza, A., Dell’Avvocata, F., Torin, G., Bulighin, F., Battaglia, Y., & Fiorini, F. (2023) · Current Hypertension Reports · doi:10.1007/s11906-023-01264-2 · Cited by 14
Васильевич, И. М., Emelyanov, I. V., Vakhrushev, A. D., Alieva, A. S., Avdonina, N., Yudina, Y., Lebedev, D. S., Михайлов, Е. Н., & Конради, А. О. (2022) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2022-4794 · Cited by 8
Iliakis, P., Dimitriadis, K. S., Tatakis, F., Vakka, A., Sakalidis, A., Pyrpyris, N., Fragoulis, C., Konstantinidis, D., Aznaouridis, K. A., & Tsioufis, K. P. (2025) · Biomedicines · doi:10.3390/biomedicines13081951 · Cited by 11
Liu, S., Bian, R., Qian, Y., Liao, H., Gao, X., Zhang, Y., & Dong, W. (2022) · Journal of Clinical Hypertension · doi:10.1111/jch.14605 · Cited by 10
Lo, H.-Y., Lee, J., & Lin, Y. (2024) · Hypertension Research · doi:10.1038/s41440-023-01540-3 · Cited by 9
Renal denervation is effective in reducing blood pressure in patients with CKD
Bosch, A., Kannenkeril, D., & Schmieder, R. E. (2025) · Clinical Kidney Journal · doi:10.1093/ckj/sfaf126 · Cited by 7
Self-citationRenal Denervation in Hypertension and Chronic Heart Failure
Lauder, L., Fisher, N. D. L., Böhm, M., Pfister, O., Secemsky, E. A., Taub, P. R., & Mahfoud, F. (2025) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2025.06.022 · Cited by 6
Self-citationBytyqi, V., Kannenkeril, D., Schmid, A., Striepe, K., Bosch, A., Karg, M. V., Schiffer, M., Uder, M., & Schmieder, R. E. (2025) · Clinical Kidney Journal · doi:10.1093/ckj/sfaf184 · Cited by 9
Self-citation2025 Update on resistant hypertension in CKD: where do we stand and where do we go?
Schmieder, R. E. (2025) · Clinical Kidney Journal · doi:10.1093/ckj/sfaf285 · Cited by 9
Self-citationLi, L., Liu, J., Huang, B., Zhang, Y., Zeng, F., Tian, P., Chen, X., Li, B., Wang, Y., Yang, H., et al. (2024) · Cardiovascular revascularization medicine · doi:10.1016/j.carrev.2024.04.294 · Cited by 5
Kario, K., Kandzari, D. E., Mahfoud, F., Weber, M. A., Schmieder, R. E., Tsioufis, K. P., Liu, M., Böhm, M., & Townsend, R. R. (2025) · Hypertension Research · doi:10.1038/s41440-025-02186-z · Cited by 5
Self-citationAspects of renal function and renal artery anatomy as indications for renal denervation
Ogoyama, Y., & Kario, K. (2024) · Hypertension Research · doi:10.1038/s41440-024-01860-y · Cited by 4
I Brazilian guideline on hypertension in dialysis of the Brazilian Society of Nephrology
Rodrigues, C. I. S., Filho, S. R. F., Moura, A. F., Poli‐de‐Figueiredo, C. E., da Silva, D. R., Gorayeb-Polacchini, F. S., de Almeida, F. A., Pinheiro, M. E., Bezerra, R., de Paula, R. B., et al. (2025) · Brazilian Journal of Nephrology · doi:10.1590/2175-8239-jbn-2024-0033en · Cited by 10
Burnier, M. (2021) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfab208 · Cited by 4
Renal Denervation: Patient Selection and When to Refer
Voora, R. A., Bloch, M. J., & Fisher, N. D. L. (2025) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2025.06.009 · Cited by 3
Radio Frequency-Based Renal Denervation: A Story of Simplicity?
Götzinger, F., Kunz, M., Lauder, L., Mahfoud, F., & Böhm, M. (2023) · Future Cardiology · doi:10.2217/fca-2023-0059 · Cited by 4
Self-citationRenal denervation in patients with chronic kidney disease: an approach using CO2 angiography
Shinohara, K. (2024) · Hypertension Research · doi:10.1038/s41440-024-01635-5 · Cited by 5
Measuring Success in Renal Denervation: Response Parameters and Predictors of Response
Lee, H., Sharp, A. S. P., & Secemsky, E. A. (2025) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2025.07.017 · Cited by 2
Galli, V., Galuppi, E., Tavella, D., Gangemi, C., Gambaro, A., Casal, M., Trevisanello, A., Fezzi, S., Scarsini, R., Ferrero, V., et al. (2025) · EuroIntervention · doi:10.4244/eij-d-25-00217 · Cited by 2
Kidney Denervation: Latest Breakthroughs and Insights
Bahrainwala, J. Z., Etemadi, A., & Chang, T. I. (2025) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.0000000972 · Cited by 2
Zyubanova, I. V., Игоревна, Р. Н., Mordovin, V. F., Manukyan, M. A., Lichikaki, V., Solonskaya, E., Gusakova, A., Суслова, Т. Е., Pekarskiy, S. E., Хунхинова, С. А., et al. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1501296 · Cited by 2
The impact of renal denervation procedure on use of antihypertensive drugs in the real-life setting
Rea, F., Morabito, G., Savaré, L., Corrao, G., & Mancia, G. (2022) · Blood Pressure · doi:10.1080/08037051.2022.2126345 · Cited by 2
Self-citationAdvances in Renal Denervation in the Treatment of Hypertension
Xiong, B., Chen, S., Chen, W., Yin, Y., & Ling, Z. (2023) · Cardiovascular Innovations and Applications · doi:10.15212/cvia.2023.0014 · Cited by 4
Jelaković, B., Perkov, D., Barišić, K., Bukal, N., Gellineo, L., Jelaković, A., Josipović, J., Prkačin, I., Vrkić, T. Ž., & Živko, M. (2023) · Vascular Health and Risk Management · doi:10.2147/vhrm.s422773 · Cited by 3
Zuo, X., Xiao, Y., Zhang, Z., Xie, J., Wang, F., Wu, K., Xi, Q., Peng, Y., Liu, K., & Chen, X. (2025) · Hypertension Research · doi:10.1038/s41440-025-02464-w · Cited by 1
Patient Selection and Renal Denervation
Ashoka, A., & Voora, R. A. (2026) · Current Hypertension Reports · doi:10.1007/s11906-025-01360-5 · Cited by 2
Three‐Year Durability of Radiofrequency Renal Denervation: SPYRAL HTN‐ON MED
Kandzari, D. E., Mahfoud, F., Townsend, R. R., Kario, K., Weber, M. A., Schmieder, R. E., Tsioufis, K. P., Pocock, S., Yang, G., Brar, S. K., et al. (2026) · Journal of the American Heart Association · doi:10.1161/jaha.126.049081 · Cited by 3
Self-citationPleiotropic effects of renal denervation beyond blood pressure reduction
Vakka, A., Kyriakoulis, K. G., Tatakis, F., Iliakis, P., Kalliakouda, E., Papadomarkaki, K., Damianaki, A., Dimitriadis, K. P., Konstantinidis, D., & Tsioufis, K. P. (2026) · Hypertension Research · doi:10.1038/s41440-026-02699-1 · Cited by 1
Renal denervation as therapeutic intervention
Esler, M., Lambert, G. W., Lambert, É., Guo, L. J., & Schlaich, M. P. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-85492-4.00088-0 · Cited by 1
Self-citationI Diretriz Brasileira de hipertensão arterial na diálise da Sociedade Brasileira de Nefrologia
Rodrigues, C. I. S., Filho, S. R. F., Moura, A. F., Poli‐de‐Figueiredo, C. E., da Silva, D. R., Gorayeb-Polacchini, F. S., de Almeida, F. A., Pinheiro, M. E., Bezerra, R., de Paula, R. B., et al. (2025) · Brazilian Journal of Nephrology · doi:10.1590/2175-8239-jbn-2024-0033pt · Cited by 4
Renale Denervation: Wirklich eine Alternative zu Blutdrucksenkern?
Striepe, K., Schiffer, M., & Schmieder, R. E. (2022) · Der Internist · doi:10.1007/s00108-021-01242-3
Self-citationTreatment of Hypertension in Chronic Kidney Disease
Redón, J. (2025) · Updates in hypertension and cardiovascular protection · doi:10.1007/978-3-031-81292-7_15
Proteinuria and renal function in hypertension: a role for the renal nerves
Veiga, A. C., Silva-Aguiar, R. P., Campos, R. R., Bergamaschi, C. T., Caruso‐Neves, C., & Nishi, E. E. (2025) · Journal of Hypertension · doi:10.1097/hjh.0000000000004201
Manukyan, M., Mordovin, V. F., Pekarskiy, S. E., Zyubanova, I. V., Lichikaki, V. A., Solonskaya, E., Хунхинова, С. А., Gusakova, A., & Falkovskaya, А. Y. (2026) · Medicina · doi:10.3390/medicina62020274 · Cited by 2
Chinese expert consensus on percutaneous renal denervation therapy for hypertension (2025 edition)
National Clinical Research Center for Interventional Medicine, C. H. H. (2026) · Cardiology Plus · doi:10.1097/cp9.0000000000000149
Aires, R. S., Silva, M. D. C. C., Barbosa, F. D. M., da Silva, M. C., Alves, S. M. D. L., Araújo, A. V., & de Queiroz, T. M. (2026) · Pharmaceuticals · doi:10.3390/ph19050676
Renal Denervation for Hypertension in Chronic Kidney Disease
Bosch, A., & Schmieder, R. E. (2026) · Updates in hypertension and cardiovascular protection · doi:10.1007/978-3-032-29564-4_19
Self-citationRenal denervation triage tool: a practical approach to the management of resistant hypertension
Kalra, S., Schlaich, M. P., Bhalla, A. K., Almeida, A., Kapadia, A. A., Maheshwari, A., Saboo, B., Nadkar, M., Soni, N. K., Hazra, P. K., et al. (2026) · AsiaIntervention · doi:10.4244/aij-d-25-00045
Self-citationFrom endovascular therapy to perivascular therapy: A new concept and perspective
Wang, Z., Shi, P., Zhou, Y.-J., Guo, W., Cao, Y., Mao, S., & Teng, G.-J. (2026) · EngMedicine · doi:10.1016/j.engmed.2026.100164
Vetrano, S. D., Formigli, D., Rossi, L. U., Esposito, G. M., Covino, S., Moscato, F., Franco, V., & Scherillo, M. (2026) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.70920
Schmieder, R. E., Kannenkeril, D., Böhm, M., Mahfoud, F., Rump, L. C., Stegbauer, J., van der Giet, M., Meyer, M. R., Schiffer, M., Veelken, R. A., et al. (2026) · Journal of Hypertension · doi:10.1097/hjh.0000000000004482
Self-citation
Metadata
- Authors
- Ott, C., Mahfoud, F., Mancia, G., Narkiewicz, K., Ruilope, L. M., Fahy, M., Schlaich, M. P., Böhm, M., & Schmieder, R. E.
- Affiliations
- Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
- Universitätsklinikum des Saarlandes (DE)
- University of Milano-Bicocca (IT)
- Gdańsk Medical University (PL)
- Research Institute Hospital 12 de Octubre (ES)
- Medtronic (United States) (US)
- The University of Western Australia (AU)
- Corresponding author
- Schmieder, Roland E
- ORCID
- Venue
- Nephrology Dialysis Transplantation
- Publisher
- Oxford University Press (OUP)
- Published
- 2021-06-09
- Volume
- 37
- Issue
- 2
- Pages
- 304-310
- ISSN
- 0931-0509 (ISSN-L)
- 1460-2385
- OpenAlex
- W3171343307
- Cited by
- 62
- References
- 36
- Citations by year
- 2026: 11 · 2025: 19 · 2024: 10 · 2023: 9 · 2022: 10 · 2021: 3
- FWCI
- 5.36
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Nephrology Dialysis Transplantation (publishedVersion)
- PubMed (publishedVersion)
- UWA Profiles and Research Repository (UWA) (submittedVersion)
- BOA (University of Milano-Bicocca) (submittedVersion)
- Funders
- Medtronic
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Nephrology › Renal and Vascular Pathologies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
- Keywords
- renal denervation, chronic kidney disease, hypertension, blood pressure reduction, ambulatory blood pressure, office blood pressure, estimated glomerular filtration rate, sympathetic nervous system, antihypertensive therapy
- MeSH terms
- Antihypertensive Agents, Blood Pressure, Denervation, Follow-Up Studies, Humans, Hypertension, Kidney, Registries, Sympathectomy, Treatment Outcome, Renal Insufficiency, Chronic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.